Movement Disorders, ISSN 0885-3185, 06/2014, Volume 29, Issue 7, pp. 857 - 867
ABSTRACT Consensus diagnostic criteria for multiple system atrophy consider dementia as a nonsupporting feature, despite emerging evidence demonstrating that...
cognition | neuropsychology | multiple system atrophy | Multiple system atrophy | Cognition | Neuropsychology | FRONTAL-LOBE | DAYTIME SLEEPINESS | BRAIN GLUCOSE-METABOLISM | DEPRESSIVE SYMPTOMS | CEREBRAL ATROPHY | STRIATONIGRAL DEGENERATION | CLINICAL NEUROLOGY | VOXEL-BASED MORPHOMETRY | CEREBELLAR VARIANT | IDIOPATHIC PARKINSONS-DISEASE | PROGRESSIVE SUPRANUCLEAR PALSY | Multiple System Atrophy - therapy | Humans | Dementia - diagnosis | Multiple System Atrophy - complications | Neuropsychological Tests | Cognition Disorders - diagnosis | Dementia - etiology | Animals | Cognition Disorders - etiology | Cognition - physiology | Cognition Disorders - therapy | Multiple System Atrophy - diagnosis | Memory - physiology | Atrophy | Task forces | Dementia
cognition | neuropsychology | multiple system atrophy | Multiple system atrophy | Cognition | Neuropsychology | FRONTAL-LOBE | DAYTIME SLEEPINESS | BRAIN GLUCOSE-METABOLISM | DEPRESSIVE SYMPTOMS | CEREBRAL ATROPHY | STRIATONIGRAL DEGENERATION | CLINICAL NEUROLOGY | VOXEL-BASED MORPHOMETRY | CEREBELLAR VARIANT | IDIOPATHIC PARKINSONS-DISEASE | PROGRESSIVE SUPRANUCLEAR PALSY | Multiple System Atrophy - therapy | Humans | Dementia - diagnosis | Multiple System Atrophy - complications | Neuropsychological Tests | Cognition Disorders - diagnosis | Dementia - etiology | Animals | Cognition Disorders - etiology | Cognition - physiology | Cognition Disorders - therapy | Multiple System Atrophy - diagnosis | Memory - physiology | Atrophy | Task forces | Dementia
Journal Article
Clinical Neurophysiology, ISSN 1388-2457, 02/2016, Volume 127, Issue 2, pp. 1491 - 1502
Objective: Patients with multiple system atrophy (MSA) are classified into those mainly manifesting cerebellar ataxia (MSA-C) and those mainly manifesting...
Cerebellum | Multiple system atrophy | Saccade | Basal ganglia | Parkinson's disease | Pathophysiology | DIFFERENTIAL-DIAGNOSIS | STRIATONIGRAL DEGENERATION | NEUROSCIENCES | EYE-MOVEMENTS | CLINICAL NEUROLOGY | FUNCTIONAL-PROPERTIES | SUPERIOR COLLICULUS | GABA-RELATED SUBSTANCES | MONKEY CAUDATE NEURONS | INHIBITORY CONTROL | CONSENSUS STATEMENT | Parkinsonian Disorders - physiopathology | Cerebellar Ataxia - epidemiology | Humans | Middle Aged | Parkinsonian Disorders - diagnosis | Parkinsonian Disorders - epidemiology | Spinocerebellar Ataxias - epidemiology | Male | Spinocerebellar Ataxias - physiopathology | Multiple System Atrophy - epidemiology | Cerebellar Ataxia - physiopathology | Spinocerebellar Ataxias - diagnosis | Female | Saccades - physiology | Aged | Multiple System Atrophy - diagnosis | Multiple System Atrophy - physiopathology | Cerebellar Ataxia - diagnosis | Atrophy | Medicine, Experimental | Medical research | Neurosciences | Spinocerebellar ataxia
Cerebellum | Multiple system atrophy | Saccade | Basal ganglia | Parkinson's disease | Pathophysiology | DIFFERENTIAL-DIAGNOSIS | STRIATONIGRAL DEGENERATION | NEUROSCIENCES | EYE-MOVEMENTS | CLINICAL NEUROLOGY | FUNCTIONAL-PROPERTIES | SUPERIOR COLLICULUS | GABA-RELATED SUBSTANCES | MONKEY CAUDATE NEURONS | INHIBITORY CONTROL | CONSENSUS STATEMENT | Parkinsonian Disorders - physiopathology | Cerebellar Ataxia - epidemiology | Humans | Middle Aged | Parkinsonian Disorders - diagnosis | Parkinsonian Disorders - epidemiology | Spinocerebellar Ataxias - epidemiology | Male | Spinocerebellar Ataxias - physiopathology | Multiple System Atrophy - epidemiology | Cerebellar Ataxia - physiopathology | Spinocerebellar Ataxias - diagnosis | Female | Saccades - physiology | Aged | Multiple System Atrophy - diagnosis | Multiple System Atrophy - physiopathology | Cerebellar Ataxia - diagnosis | Atrophy | Medicine, Experimental | Medical research | Neurosciences | Spinocerebellar ataxia
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2009, Volume 8, Issue 12, pp. 1172 - 1178
Summary Multiple system atrophy (MSA) is a sporadic and rapidly progressive neurodegenerative disorder that presents with autonomic failure in combination with...
Neurology | OLIVOPONTOCEREBELLAR ATROPHY | DELAYED-START TRIAL | AUTONOMIC DYSFUNCTION | GROUP EMSA-SG | GLIAL CYTOPLASMIC INCLUSIONS | DOUBLE-BLIND | ALPHA-SYNUCLEIN | TRANSGENIC MOUSE MODEL | CLINICAL NEUROLOGY | PROGRESSIVE SUPRANUCLEAR PALSY | PARKINSONS-DISEASE | Multiple System Atrophy - therapy | Excitatory Amino Acid Antagonists - therapeutic use | Prognosis | Multiple System Atrophy - pathology | Humans | Riluzole - therapeutic use | alpha-Synuclein - genetics | Multiple System Atrophy - genetics | Multiple System Atrophy - epidemiology | Multiple System Atrophy - etiology | Atrophy | Neuroimaging | Basal ganglia | Neurodegenerative diseases | Autonomic nervous system | Cerebellar ataxia | Central nervous system diseases | Clinical trials | Minocycline | Growth hormone | Epidemiology | Movement disorders
Neurology | OLIVOPONTOCEREBELLAR ATROPHY | DELAYED-START TRIAL | AUTONOMIC DYSFUNCTION | GROUP EMSA-SG | GLIAL CYTOPLASMIC INCLUSIONS | DOUBLE-BLIND | ALPHA-SYNUCLEIN | TRANSGENIC MOUSE MODEL | CLINICAL NEUROLOGY | PROGRESSIVE SUPRANUCLEAR PALSY | PARKINSONS-DISEASE | Multiple System Atrophy - therapy | Excitatory Amino Acid Antagonists - therapeutic use | Prognosis | Multiple System Atrophy - pathology | Humans | Riluzole - therapeutic use | alpha-Synuclein - genetics | Multiple System Atrophy - genetics | Multiple System Atrophy - epidemiology | Multiple System Atrophy - etiology | Atrophy | Neuroimaging | Basal ganglia | Neurodegenerative diseases | Autonomic nervous system | Cerebellar ataxia | Central nervous system diseases | Clinical trials | Minocycline | Growth hormone | Epidemiology | Movement disorders
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 09/2017, Volume 88, Issue 9, pp. 780 - 788
IntroductionThe cerebellum has strong cortical and subcortical connectivity, but is rarely taken into account for clinical diagnosis in many neurodegenerative...
META-ANALYSIS | MRI | DEMENTIA | SURGERY | PSYCHIATRY | ALZHEIMERS-DISEASE | FRONTOTEMPORAL DEMENTIA | COGNITIVE IMPAIRMENT | INTRINSIC FUNCTIONAL CONNECTIVITY | CLINICAL NEUROLOGY | VOXEL-BASED MORPHOMETRY | MULTIPLE SYSTEM ATROPHY | GRAY-MATTER ATROPHY | HUNTINGTONS-DISEASE | PROGRESSIVE SUPRANUCLEAR PALSY | PARKINSONS-DISEASE | Neurodegenerative Diseases - diagnosis | Cerebellar Ataxia | Humans | Atrophy - pathology | Gray Matter - pathology | Cerebellum - pathology | Atrophy | Nervous system | Reports | Degeneration | Research | Huntingtons disease | Medical imaging | Neurodegeneration | Parkinsons disease | Amyotrophic lateral sclerosis | Ataxia | Alzheimers disease | Dementia
META-ANALYSIS | MRI | DEMENTIA | SURGERY | PSYCHIATRY | ALZHEIMERS-DISEASE | FRONTOTEMPORAL DEMENTIA | COGNITIVE IMPAIRMENT | INTRINSIC FUNCTIONAL CONNECTIVITY | CLINICAL NEUROLOGY | VOXEL-BASED MORPHOMETRY | MULTIPLE SYSTEM ATROPHY | GRAY-MATTER ATROPHY | HUNTINGTONS-DISEASE | PROGRESSIVE SUPRANUCLEAR PALSY | PARKINSONS-DISEASE | Neurodegenerative Diseases - diagnosis | Cerebellar Ataxia | Humans | Atrophy - pathology | Gray Matter - pathology | Cerebellum - pathology | Atrophy | Nervous system | Reports | Degeneration | Research | Huntingtons disease | Medical imaging | Neurodegeneration | Parkinsons disease | Amyotrophic lateral sclerosis | Ataxia | Alzheimers disease | Dementia
Journal Article
Neurology, ISSN 0028-3878, 08/2008, Volume 71, Issue 9, pp. 670 - 676
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2013, Volume 369, Issue 3, pp. 233 - 244
Multiple-system atrophy is a rare neurodegenerative disease characterized by autonomic failure. Mutations affecting an enzyme essential for the synthesis of...
SKELETAL-MUSCLE | MEDICINE, GENERAL & INTERNAL | OLIVOPONTOCEREBELLAR ATROPHY | OXIDATIVE STRESS | IMMUNOREACTIVITY | VARIANTS | GLIAL CYTOPLASMIC INCLUSIONS | ALPHA-SYNUCLEIN | TRANSGENIC MOUSE MODEL | PARKINSONS-DISEASE | DEGENERATION | Cell Line | Ubiquinone - analysis | Humans | Ubiquinone - analogs & derivatives | Male | Multiple System Atrophy - genetics | Alkyl and Aryl Transferases - genetics | DNA Mutational Analysis | Pedigree | Female | Brain Chemistry | Mutation | Genetic Linkage | Atrophy | Ubiquinones | Genetic aspects | Research | Gene mutations | Risk factors | Cerebellum | Basal ganglia | Disease | Cerebellar ataxia | Central nervous system diseases | Genomes | High-performance liquid chromatography | Enzymatic activity | Neurodegeneration | Autonomic nervous system | Autopsy | Coenzyme Q10 | Genetics | Ataxia | Complementation | Movement disorders | Linkage analysis
SKELETAL-MUSCLE | MEDICINE, GENERAL & INTERNAL | OLIVOPONTOCEREBELLAR ATROPHY | OXIDATIVE STRESS | IMMUNOREACTIVITY | VARIANTS | GLIAL CYTOPLASMIC INCLUSIONS | ALPHA-SYNUCLEIN | TRANSGENIC MOUSE MODEL | PARKINSONS-DISEASE | DEGENERATION | Cell Line | Ubiquinone - analysis | Humans | Ubiquinone - analogs & derivatives | Male | Multiple System Atrophy - genetics | Alkyl and Aryl Transferases - genetics | DNA Mutational Analysis | Pedigree | Female | Brain Chemistry | Mutation | Genetic Linkage | Atrophy | Ubiquinones | Genetic aspects | Research | Gene mutations | Risk factors | Cerebellum | Basal ganglia | Disease | Cerebellar ataxia | Central nervous system diseases | Genomes | High-performance liquid chromatography | Enzymatic activity | Neurodegeneration | Autonomic nervous system | Autopsy | Coenzyme Q10 | Genetics | Ataxia | Complementation | Movement disorders | Linkage analysis
Journal Article
Neuroimage, ISSN 1053-8119, 2007, Volume 36, Issue 4, pp. 1086 - 1095
Multiple system atrophy (MSA) is a neurodegenerative disease affecting basal ganglia, brainstem, cerebellum, and intermediolateral cell columns of the spinal...
VBM | MSA-C | MSA | MSA-P | VBR | DIAGNOSIS | MRI | NATURAL-HISTORY | VARIANT | NEUROSCIENCES | NEUROIMAGING | ADULT HUMAN BRAINS | CEREBELLAR TYPE | CORTICAL ATROPHY | DIFFERENTIATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PROGRESSIVE SUPRANUCLEAR PALSY | PARKINSONS-DISEASE | Diagnosis, Differential | Olivopontocerebellar Atrophies - pathology | Pons - pathology | Putamen - pathology | Humans | Middle Aged | Parkinsonian Disorders - diagnosis | Cerebral Cortex - pathology | Male | Cephalometry | Statistics as Topic | Thalamus - pathology | Disease Progression | Cerebellum - pathology | Magnetic Resonance Imaging | Dominance, Cerebral - physiology | Image Processing, Computer-Assisted | Nerve Fibers, Myelinated - pathology | Sensitivity and Specificity | Brain - pathology | Female | Aged | Multiple System Atrophy - diagnosis | Studies | Brain | Nuclear magnetic resonance--NMR
VBM | MSA-C | MSA | MSA-P | VBR | DIAGNOSIS | MRI | NATURAL-HISTORY | VARIANT | NEUROSCIENCES | NEUROIMAGING | ADULT HUMAN BRAINS | CEREBELLAR TYPE | CORTICAL ATROPHY | DIFFERENTIATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PROGRESSIVE SUPRANUCLEAR PALSY | PARKINSONS-DISEASE | Diagnosis, Differential | Olivopontocerebellar Atrophies - pathology | Pons - pathology | Putamen - pathology | Humans | Middle Aged | Parkinsonian Disorders - diagnosis | Cerebral Cortex - pathology | Male | Cephalometry | Statistics as Topic | Thalamus - pathology | Disease Progression | Cerebellum - pathology | Magnetic Resonance Imaging | Dominance, Cerebral - physiology | Image Processing, Computer-Assisted | Nerve Fibers, Myelinated - pathology | Sensitivity and Specificity | Brain - pathology | Female | Aged | Multiple System Atrophy - diagnosis | Studies | Brain | Nuclear magnetic resonance--NMR
Journal Article
BMC Neurology, ISSN 1471-2377, 12/2015, Volume 15, Issue 1, p. 260
Background: Dentatorubropallidoluysian atrophy (DRPLA) is a rare autosomal dominant neurodegenerative disease that is associated with numerous movement...
Ataxia | Optic atrophy | Dystonia | Dentatorubropallidoluysian Atrophy (DRPLA) | African American | AMERICAN | SPINOCEREBELLAR ATAXIA | CEREBELLAR-ATAXIA | DISEASE | DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY | CLINICAL NEUROLOGY | DEGENERATION | Optic Atrophy - etiology | Humans | Middle Aged | Leukoencephalopathies - etiology | Myoclonic Epilepsies, Progressive - complications | Ataxia - etiology | Male | Myoclonic Epilepsies, Progressive - genetics | Dystonia - etiology | Trinucleotide Repeats - genetics | Nerve Tissue Proteins - genetics | Complications and side effects | Care and treatment | Activities of daily living | Analysis | Nervous system | Degeneration | Research | Movement disorders | Risk factors
Ataxia | Optic atrophy | Dystonia | Dentatorubropallidoluysian Atrophy (DRPLA) | African American | AMERICAN | SPINOCEREBELLAR ATAXIA | CEREBELLAR-ATAXIA | DISEASE | DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY | CLINICAL NEUROLOGY | DEGENERATION | Optic Atrophy - etiology | Humans | Middle Aged | Leukoencephalopathies - etiology | Myoclonic Epilepsies, Progressive - complications | Ataxia - etiology | Male | Myoclonic Epilepsies, Progressive - genetics | Dystonia - etiology | Trinucleotide Repeats - genetics | Nerve Tissue Proteins - genetics | Complications and side effects | Care and treatment | Activities of daily living | Analysis | Nervous system | Degeneration | Research | Movement disorders | Risk factors
Journal Article
Movement Disorders, ISSN 0885-3185, 11/2010, Volume 25, Issue 15, pp. 2604 - 2612
Multiple system atrophy (MSA) is a Parkinson's Disease (PD)‐like α‐synucleinopathy clinically characterized by dysautonomia, parkinsonism, cerebellar ataxia,...
EMSA‐SG | natural history | multiple system atrophy | Multiple system atrophy | EMSA-SG | Natural history | DISORDERS | PREVALENCE | NATURAL-HISTORY | AQUITAINE | CLINICAL NEUROLOGY | MSA | QUALITY-OF-LIFE | DYSFUNCTION | PROGRESSIVE SUPRANUCLEAR PALSY | PARKINSONS-DISEASE | Multiple System Atrophy - therapy | Parkinsonian Disorders - physiopathology | Levodopa - therapeutic use | Europe | Humans | Middle Aged | Parkinsonian Disorders - diagnosis | Hypotension, Orthostatic - physiopathology | Shy-Drager Syndrome - physiopathology | Male | Shy-Drager Syndrome - diagnosis | Hypotension, Orthostatic - diagnosis | Antiparkinson Agents - therapeutic use | Cerebellar Ataxia - physiopathology | Parkinsonian Disorders - drug therapy | Age of Onset | Female | Registries | Multiple System Atrophy - diagnosis | Multiple System Atrophy - physiopathology | Cerebellar Ataxia - diagnosis | Neurologi | Clinical Medicine | Neurology | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin
EMSA‐SG | natural history | multiple system atrophy | Multiple system atrophy | EMSA-SG | Natural history | DISORDERS | PREVALENCE | NATURAL-HISTORY | AQUITAINE | CLINICAL NEUROLOGY | MSA | QUALITY-OF-LIFE | DYSFUNCTION | PROGRESSIVE SUPRANUCLEAR PALSY | PARKINSONS-DISEASE | Multiple System Atrophy - therapy | Parkinsonian Disorders - physiopathology | Levodopa - therapeutic use | Europe | Humans | Middle Aged | Parkinsonian Disorders - diagnosis | Hypotension, Orthostatic - physiopathology | Shy-Drager Syndrome - physiopathology | Male | Shy-Drager Syndrome - diagnosis | Hypotension, Orthostatic - diagnosis | Antiparkinson Agents - therapeutic use | Cerebellar Ataxia - physiopathology | Parkinsonian Disorders - drug therapy | Age of Onset | Female | Registries | Multiple System Atrophy - diagnosis | Multiple System Atrophy - physiopathology | Cerebellar Ataxia - diagnosis | Neurologi | Clinical Medicine | Neurology | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin
Journal Article
Aktuelle Neurologie, ISSN 0302-4350, 09/2008, Volume 71, Issue 9, pp. 670 - 676
Background: A consensus conference on multiple system atrophy (MSA) in 1998 established criteria for diagnosis that have been accepted widely. Since then,...
CRITERIA | POSITRON-EMISSION-TOMOGRAPHY | ORTHOSTATIC HYPOTENSION | MSA | ATAXIA | NATURAL-HISTORY | DIFFERENTIATE | PROGRESSION | CLINICAL NEUROLOGY | PARKINSONS-DISEASE | DEGENERATION | Parkinsonian Disorders - physiopathology | Diagnosis, Differential | Basal Ganglia - physiopathology | Brain - physiopathology | Parkinsonian Disorders - diagnosis | Basal Ganglia - pathology | Cerebellum - physiopathology | Autonomic Nervous System Diseases - diagnosis | Cerebellum - pathology | Cerebellar Ataxia - physiopathology | Autonomic Nervous System Diseases - physiopathology | Brain - pathology | Inclusion Bodies - pathology | Multiple System Atrophy - diagnosis | Multiple System Atrophy - physiopathology | Inclusion Bodies - metabolism | Cerebellar Ataxia - diagnosis | alpha-Synuclein - metabolism
CRITERIA | POSITRON-EMISSION-TOMOGRAPHY | ORTHOSTATIC HYPOTENSION | MSA | ATAXIA | NATURAL-HISTORY | DIFFERENTIATE | PROGRESSION | CLINICAL NEUROLOGY | PARKINSONS-DISEASE | DEGENERATION | Parkinsonian Disorders - physiopathology | Diagnosis, Differential | Basal Ganglia - physiopathology | Brain - physiopathology | Parkinsonian Disorders - diagnosis | Basal Ganglia - pathology | Cerebellum - physiopathology | Autonomic Nervous System Diseases - diagnosis | Cerebellum - pathology | Cerebellar Ataxia - physiopathology | Autonomic Nervous System Diseases - physiopathology | Brain - pathology | Inclusion Bodies - pathology | Multiple System Atrophy - diagnosis | Multiple System Atrophy - physiopathology | Inclusion Bodies - metabolism | Cerebellar Ataxia - diagnosis | alpha-Synuclein - metabolism
Conference Proceeding
Experimental Brain Research, ISSN 0014-4819, 9/2017, Volume 235, Issue 9, pp. 2777 - 2786
Gulf War Illness (GWI) is a multisystem disorder that has affected a substantial number of veterans who served in the 1990–1991 Gulf War. The brain is...
Cerebellum | Neurology | Toxic encephalopathy | Neurosciences | Biomedicine | Brain atrophy | Brainstem | Gulf War Illness | Thalamus | CORTICAL SURFACE | PERMEABILITY | CEREBELLAR DEGENERATION | BARRIER | COORDINATE SYSTEM | VETERANS | NEUROSCIENCES | ENCEPHALOPATHY | HUMAN CEREBRAL-CORTEX | DISRUPTION | STRESS | Amygdala - diagnostic imaging | Basal Ganglia - diagnostic imaging | Thalamus - diagnostic imaging | Veterans | Humans | Middle Aged | Atrophy - pathology | Brain Stem - diagnostic imaging | Male | Basal Ganglia - pathology | Thalamus - pathology | Amygdala - pathology | Cerebellum - pathology | Magnetic Resonance Imaging | Cerebellum - diagnostic imaging | Neurotoxicity Syndromes - pathology | Brain Stem - pathology | Adult | Female | Aged | Diencephalon - diagnostic imaging | Persian Gulf Syndrome - pathology | Diencephalon - pathology | Persian Gulf Syndrome - diagnostic imaging | Physiological aspects | Brain | Persian Gulf War veterans | Health aspects | Abnormalities | Basal ganglia | Amygdala | Brain stem | Cognitive ability | Combustion products | Insecticides | Smoke | Vaccines | Atrophy | Uranium | Gulf War | Fires | Encephalopathy | Sarin | Military personnel | Persian Gulf War | Nerve agents | Solvents | Gulf War syndrome | Superior cerebellar peduncle | Exposure | Ganglia | Painting | Mood | Biological warfare | Pyridostigmine bromide | Pyridostigmine | Diencephalon | Paints
Cerebellum | Neurology | Toxic encephalopathy | Neurosciences | Biomedicine | Brain atrophy | Brainstem | Gulf War Illness | Thalamus | CORTICAL SURFACE | PERMEABILITY | CEREBELLAR DEGENERATION | BARRIER | COORDINATE SYSTEM | VETERANS | NEUROSCIENCES | ENCEPHALOPATHY | HUMAN CEREBRAL-CORTEX | DISRUPTION | STRESS | Amygdala - diagnostic imaging | Basal Ganglia - diagnostic imaging | Thalamus - diagnostic imaging | Veterans | Humans | Middle Aged | Atrophy - pathology | Brain Stem - diagnostic imaging | Male | Basal Ganglia - pathology | Thalamus - pathology | Amygdala - pathology | Cerebellum - pathology | Magnetic Resonance Imaging | Cerebellum - diagnostic imaging | Neurotoxicity Syndromes - pathology | Brain Stem - pathology | Adult | Female | Aged | Diencephalon - diagnostic imaging | Persian Gulf Syndrome - pathology | Diencephalon - pathology | Persian Gulf Syndrome - diagnostic imaging | Physiological aspects | Brain | Persian Gulf War veterans | Health aspects | Abnormalities | Basal ganglia | Amygdala | Brain stem | Cognitive ability | Combustion products | Insecticides | Smoke | Vaccines | Atrophy | Uranium | Gulf War | Fires | Encephalopathy | Sarin | Military personnel | Persian Gulf War | Nerve agents | Solvents | Gulf War syndrome | Superior cerebellar peduncle | Exposure | Ganglia | Painting | Mood | Biological warfare | Pyridostigmine bromide | Pyridostigmine | Diencephalon | Paints
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2013, Volume 12, Issue 3, pp. 264 - 274
Summary Background Multiple system atrophy (MSA) is a fatal and still poorly understood degenerative movement disorder that is characterised by autonomic...
Neurology | DIAGNOSIS | GROUP EMSA-SG | NUCLEUS | DISORDERS | SYMPTOMS | PATIENT | QUALITY-OF-LIFE | DEEP BRAIN-STIMULATION | CLINICAL NEUROLOGY | PROGRESSIVE SUPRANUCLEAR PALSY | PARKINSONS-DISEASE | Severity of Illness Index | Prospective Studies | Europe | Humans | Middle Aged | Male | Parkinson Disease - physiopathology | Autonomic Nervous System Diseases - diagnosis | Disease Progression | Autonomic Nervous System Diseases - mortality | Cerebellar Ataxia - physiopathology | Phenotype | Autonomic Nervous System Diseases - physiopathology | Parkinson Disease - diagnosis | Multiple System Atrophy - mortality | Aged | Multiple System Atrophy - classification | Multiple System Atrophy - diagnosis | Multiple System Atrophy - physiopathology | Cerebellar Ataxia - diagnosis | Cerebellar Ataxia - mortality | Cohort Studies | Parkinson Disease - mortality | Atrophy | Medical colleges | Nervous system diseases | Neurosciences | Analysis | Neurologi | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Neurology | DIAGNOSIS | GROUP EMSA-SG | NUCLEUS | DISORDERS | SYMPTOMS | PATIENT | QUALITY-OF-LIFE | DEEP BRAIN-STIMULATION | CLINICAL NEUROLOGY | PROGRESSIVE SUPRANUCLEAR PALSY | PARKINSONS-DISEASE | Severity of Illness Index | Prospective Studies | Europe | Humans | Middle Aged | Male | Parkinson Disease - physiopathology | Autonomic Nervous System Diseases - diagnosis | Disease Progression | Autonomic Nervous System Diseases - mortality | Cerebellar Ataxia - physiopathology | Phenotype | Autonomic Nervous System Diseases - physiopathology | Parkinson Disease - diagnosis | Multiple System Atrophy - mortality | Aged | Multiple System Atrophy - classification | Multiple System Atrophy - diagnosis | Multiple System Atrophy - physiopathology | Cerebellar Ataxia - diagnosis | Cerebellar Ataxia - mortality | Cohort Studies | Parkinson Disease - mortality | Atrophy | Medical colleges | Nervous system diseases | Neurosciences | Analysis | Neurologi | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article